Literature DB >> 27760826

Pleckstrin Homology (PH) Domain Leucine-rich Repeat Protein Phosphatase Controls Cell Polarity by Negatively Regulating the Activity of Atypical Protein Kinase C.

Xiaopeng Xiong1, Xin Li1, Yang-An Wen1, Tianyan Gao2,3.   

Abstract

The proper establishment of epithelial polarity allows cells to sense and respond to signals that arise from the microenvironment in a spatiotemporally controlled manner. Atypical PKCs (aPKCs) are implicated as key regulators of epithelial polarity. However, the molecular mechanism underlying the negative regulation of aPKCs remains largely unknown. In this study, we demonstrated that PH domain leucine-rich repeat protein phosphatase (PHLPP), a novel family of Ser/Thr protein phosphatases, plays an important role in regulating epithelial polarity by controlling the phosphorylation of both aPKC isoforms. Altered expression of PHLPP1 or PHLPP2 disrupted polarization of Caco2 cells grown in 3D cell cultures as indicated by the formation of aberrant multi-lumen structures. Overexpression of PHLPP resulted in a decrease in aPKC phosphorylation at both the activation loop and the turn motif sites; conversely, knockdown of PHLPP increased aPKC phosphorylation. Moreover, in vitro dephosphorylation experiments revealed that both aPKC isoforms were substrates of PHLPP. Interestingly, knockdown of PKCζ, but not PKCι, led to similar disruption of the polarized lumen structure, suggesting that PKCζ likely controls the polarization process of Caco2 cells. Furthermore, knockdown of PHLPP altered the apical membrane localization of aPKCs and reduced the formation of aPKC-Par3 complex. Taken together, our results identify a novel role of PHLPP in regulating aPKC and cell polarity.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Akt PKB; PHLPP; atypical PKC; cell polarity; dephosphorylation; phosphatase; protein kinase C (PKC); protein phosphorylation

Mesh:

Substances:

Year:  2016        PMID: 27760826      PMCID: PMC5122783          DOI: 10.1074/jbc.M116.740639

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  The phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation.

Authors:  Claudia Nitsche; Mouad Edderkaoui; Ryan M Moore; Guido Eibl; Noriyuki Kasahara; Janet Treger; Paul J Grippo; Julia Mayerle; Markus M Lerch; Anna S Gukovskaya
Journal:  Gastroenterology       Date:  2011-10-29       Impact factor: 22.682

2.  Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer.

Authors:  Astrid M Eder; Xiaomei Sui; Daniel G Rosen; Laura K Nolden; Kwai Wa Cheng; John P Lahad; Madhuri Kango-Singh; Karen H Lu; Carla L Warneke; Edward N Atkinson; Isabelle Bedrosian; Khandan Keyomarsi; Wen-lin Kuo; Joe W Gray; Jerry C P Yin; Jinsong Liu; Georg Halder; Gordon B Mills
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-22       Impact factor: 11.205

Review 3.  The Par3/Par6/aPKC complex and epithelial cell polarity.

Authors:  Jia Chen; Mingjie Zhang
Journal:  Exp Cell Res       Date:  2013-03-25       Impact factor: 3.905

4.  PHLPP-mediated dephosphorylation of S6K1 inhibits protein translation and cell growth.

Authors:  Jianyu Liu; Payton D Stevens; Xin Li; Micheal D Schmidt; Tianyan Gao
Journal:  Mol Cell Biol       Date:  2011-10-10       Impact factor: 4.272

5.  Scribble-mediated membrane targeting of PHLPP1 is required for its negative regulation of Akt.

Authors:  Xin Li; Haihua Yang; Jianyu Liu; Micheal D Schmidt; Tianyan Gao
Journal:  EMBO Rep       Date:  2011-06-24       Impact factor: 8.807

Review 6.  Molecular requirements for epithelial-mesenchymal transition during tumor progression.

Authors:  Margit A Huber; Norbert Kraut; Hartmut Beug
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

7.  Loss of PHLPP protects against colitis by inhibiting intestinal epithelial cell apoptosis.

Authors:  Yang-An Wen; Xin Li; Tatiana Goretsky; Heidi L Weiss; Terrence A Barrett; Tianyan Gao
Journal:  Biochim Biophys Acta       Date:  2015-07-15

8.  PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth.

Authors:  Tianyan Gao; Frank Furnari; Alexandra C Newton
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

Review 9.  LKB1 tumor suppressor protein: PARtaker in cell polarity.

Authors:  Annette F Baas; Linda Smit; Hans Clevers
Journal:  Trends Cell Biol       Date:  2004-06       Impact factor: 20.808

10.  Regulation of protein kinase C zeta by PI 3-kinase and PDK-1.

Authors:  M M Chou; W Hou; J Johnson; L K Graham; M H Lee; C S Chen; A C Newton; B S Schaffhausen; A Toker
Journal:  Curr Biol       Date:  1998-09-24       Impact factor: 10.834

View more
  6 in total

1.  Deficiency in the phosphatase PHLPP1 suppresses osteoclast-mediated bone resorption and enhances bone formation in mice.

Authors:  Anna M Mattson; Dana L Begun; David H H Molstad; Margaret A Meyer; Merry Jo Oursler; Jennifer J Westendorf; Elizabeth W Bradley
Journal:  J Biol Chem       Date:  2019-06-12       Impact factor: 5.157

Review 2.  PHLPPing the balance: restoration of protein kinase C in cancer.

Authors:  Hannah Tovell; Alexandra C Newton
Journal:  Biochem J       Date:  2021-01-29       Impact factor: 3.857

3.  Molecular mechanism of the TP53-MDM2-AR-AKT signalling network regulation by USP12.

Authors:  Urszula L McClurg; Nay C T H Chit; Mahsa Azizyan; Joanne Edwards; Arash Nabbi; Karl T Riabowol; Sirintra Nakjang; Stuart R McCracken; Craig N Robson
Journal:  Oncogene       Date:  2018-05-14       Impact factor: 9.867

4.  Erbin Suppresses KSR1-Mediated RAS/RAF Signaling and Tumorigenesis in Colorectal Cancer.

Authors:  Payton D Stevens; Yang-An Wen; Xiaopeng Xiong; Yekaterina Y Zaytseva; Austin T Li; Chi Wang; Ashley T Stevens; Trevor N Farmer; Tong Gan; Heidi L Weiss; Masaki Inagaki; Sylvie Marchetto; Jean-Paul Borg; Tianyan Gao
Journal:  Cancer Res       Date:  2018-07-06       Impact factor: 13.312

5.  Activation of Drp1 promotes fatty acids-induced metabolic reprograming to potentiate Wnt signaling in colon cancer.

Authors:  Xiaopeng Xiong; Sumati Hasani; Lyndsay E A Young; Dylan R Rivas; Ashley T Skaggs; Rebecca Martinez; Chi Wang; Heidi L Weiss; Matthew S Gentry; Ramon C Sun; Tianyan Gao
Journal:  Cell Death Differ       Date:  2022-03-24       Impact factor: 12.067

6.  Downregulation of PHLPP induced by endoplasmic reticulum stress promotes eIF2α phosphorylation and chemoresistance in colon cancer.

Authors:  Bianqin Guo; Xiaopeng Xiong; Sumati Hasani; Yang-An Wen; Austin T Li; Rebecca Martinez; Ashley T Skaggs; Tianyan Gao
Journal:  Cell Death Dis       Date:  2021-10-18       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.